Starting from 7 a and 7 b, ligands that exhibited a preference for BD1 of BET family members, the novel active compounds have been developed by the bioisosteric replacement of the unfavorable azobenzene moiety, that could give rise to toxic metabolites in particular in hypoxic tumor microenvironments, with a benzimidazole ring. This evidence concerns the gene DNER and neoplasm.